Oncology Institute (TOI) Short-term Investments (2022 - 2024)

Oncology Institute has reported Short-term Investments for 3 years, with the latest figure at $9.9 million in Q2 2024.

• For the quarter ending Q2 2024, Short-term Investments fell 3.42% year-over-year to $9.9 million; the trailing twelve-month figure through Jun 2024 stood at $9.9 million (down 3.42% YoY), and the FY2023 full-year result was $49.4 million, down 17.44% from the prior year.
• Short-term Investments for Q2 2024 stood at $9.9 million, down from $29.8 million in the prior quarter.
• The five-year high for Short-term Investments was $59.9 million in Q3 2023, with the low at $9.9 million in Q2 2024.
• Historically, Short-term Investments has averaged $36.0 million across 3 years, with a median of $35.0 million in 2023.
• Annual changes were most pronounced in 2023 — Short-term Investments jumped 105.38% — and 2024, when it declined 25.8%.
• Oncology Institute's Short-term Investments stood at $59.8 million in 2022, then fell by 17.44% to $49.4 million in 2023, then tumbled by 79.87% to $9.9 million in 2024.
• The last three Short-term Investments figures came in at $9.9 million (Q2 2024), $29.8 million (Q1 2024), and $49.4 million (Q4 2023), per Business Quant data.